🇺🇸 FDA
Pipeline program

VYN201 Gel

VY2024-02

Phase 2 small_molecule terminated

Quick answer

VYN201 Gel for Non-segmental Vitiligo is a Phase 2 program (small_molecule) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
VYNE Therapeutics
Indication
Non-segmental Vitiligo
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials